Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Mao, Pingping ^a   Hever Jardine, Mary P ^a   Rahme, Gilbert J ^a   Yang, Eric ^a   Tam, Janice ^a   Kodali, Anita ^a   Biswal, Bijesh ^a   Fadul, Camilo E ^a,b   Gaur, Arti ^a,b   Israel, Mark A ^a,b   Spinella, Michael J ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; PROTEIN SERINE THREONINE KINASE; STK17A PROTEIN, HUMAN;

BRAIN NEOPLASMS; CANCER GRADING; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; DEFICIENCY; DNA DAMAGE; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; BRAIN NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM GRADING; PROTEIN-SERINE-THREONINE KINASES; SURVIVAL ANALYSIS;

EID: 84894276863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081803     Document Type: Article

References (35)

1. Goodengerger ML, Jenkins RB (2005) Genetics of adult glioma. Cancer Genet 205: 613-621.
2. Tran B, Rosenthal MA (2010) Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci 17: 417-421. doi:10.1016/j.jocn.2009.09.004. PubMed: 20167494.
3. Robertson T, Koszyca B, Gonzales M (2011) Overview and recent advances in neuropathology. Part 1: Central nervous system tumours. Pathology 43: 88-92. doi:10.1097/PAT.0b013e3283426e86. PubMed: 21233669.
4. Gupta K, Salunke P (2012) Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol 138: 1971-1981. doi:10.1007/s00432-012-1323-y. PubMed: 23052697.
5. Anton K, Baehring JM, Mayer T (2012) Glioblastoma multiforme: Overview of current treatment and future perspectives. Hematol Oncol Clin North Am 26: 825-853. doi:10.1016/j.hoc.2012.04.006. PubMed: 22794286.
6. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068. doi:10.1038/nature07385. PubMed: 18772890.
7. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ et al. (2008) An integrated genomic analysis of human glioblastoma mutltiforme. Science 321: 1807-1812. doi:10.1126/science.1164382. PubMed: 18772396.
8. England B, Huang T, Karsy M (2013) Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme. Tumor Biol. In press
9. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110. doi:10.1016/j.ccr.2009.12.020. PubMed: 20129251.
10. Polivka J Jr, Polivka J, Rohan V, Topolcan O, Ferda J (2012) New molecularly targeted therapies for glioblastoma multiforme. Anticancer Res 32: 2935-2946. PubMed: 22753758.
11. Hegi ME, Rajakannu P, Weller M (2012) Epidermal growth factor receptor: a re-emerging target in glioblastoma. Curr Opin Neurol 25: 774-779. doi:10.1097/WCO.0b013e328359b0bc. PubMed: 23007009.
12. Temmerman K, Simon B, Wilmanns M (2013) Structural and functional diversity in the activity and regulation of DAPK-related protein kinases. FEBS J. In press
13. Bialik S, Kimchi A (2006) The death-associated protein kinases: structure, function, and beyond. Annu Rev Biochem 75: 189-210. doi:10.1146/annurev.biochem.75.103004.142615. PubMed: 16756490.
14. Sanjo H, Kawai T, Akira S (1998) DRAKs, novel serine/threonine kinases related to death associated protein kinase that trigger apoptosis. J Biol Chem 273: 29066-29071. doi:10.1074/jbc.273.44.29066. PubMed: 9786912.
15. Lin Y, Hupp TR, Stevens C (2010) Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death. FEBS J 277: 48-57. doi:10.1111/j.1742-4658.2009.07411.x. PubMed: 19878313.
16. Gozuacik D, Kimchi A (2006) DAPK protein family and cancer. Autophagy 2: 74-79. PubMed: 17139808.
17. Kuo JC, Lin JR, Staddon JM, Hosoya H, Chen RH (2003) Uncoordinated regulation of stress fibers and focal adhesions by DAP kinase. J Cell Sci 116: 4777-4790. doi:10.1242/jcs.00794. PubMed: 14600263.
18. Mao P, Hever MP, Niemaszyk LM, Haghkerdar JM, Yanco EG et al. (2011) Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells. J Biol Chem 286: 19381-19391. doi:10.1074/jbc.M111.218040. PubMed: 21489989.
19. Sun L, Hui AM, Vortmeyer A, Kotliarov Y, Pastorino S et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300. doi:10.1016/j.ccr.2006.03.003. PubMed: 16616334.
20. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102: 5814-5819. doi:10.1073/pnas.0402870102. PubMed: 15827123.
21. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H et al. (2005) Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65: 8679-8689. doi:10.1158/0008-5472.CAN-05-1204. PubMed: 16204036.
22. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T et al. (2008) Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26: 3015-3024. doi:10.1200/JCO.2007.15.7164. PubMed: 18565887.
23. French PJ, Swagemakers SM, Nagel JH, Kouwenhoven MC, Brouwer E et al. (2005) Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res 65: 11335-11344. doi: 10.1158/0008-5472.CAN-05- 1886. PubMed: 16357140.
24. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA et al. (2012) The cancer cell line encyclopedia enables predictive modeling of anticancer drug sensitivity. Nature 483: 603-607. doi:10.1038/nature11003. PubMed: 22460905.
25. Robertson F, Pinal N, Fichelson P, Pichaud F (2012) Atonal and EGFR signaling orchestrate rok- and Drak-dependent adherens junction remodeling during ommatidia morphogenesis. Development 139: 3432-3441.
26. Kiger AA, Baum B, Jones S, Jones MR, Coulson A et al. (2003) A functional genomic analysis of cell morphology using RNA interference. J Biol 2: 27. doi:10.1186/1475-4924-2-27. PubMed: 14527345.
27. Neubueser D, Hipfner DR (2010) Overlapping roles of Drosophila Drak and Rok kinases in epithelial tissue morphogenesis. Mol Biol Cell 21: 2869-2879. doi:10.1091/mbc.E10-04-0328. PubMed: 20573980.
28. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483: 570-575. doi:10.1038/nature11005. PubMed: 22460902.
29. Zalckvar E, Berissi H, Eisenstein M, Kimchi A (2009) Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy. 5: 720-722. doi:10.4161/auto.5.5.8625. PubMed: 19395874.
30. Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A (2002) DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 157: 455-468. doi:10.1083/jcb.200109094. PubMed: 11980920.
31. Weller M (1998) Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res 292: 435-445. doi:10.1007/s004410051072. PubMed: 9582400.
32. Peller S (1998) Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response. Semin Cancer Biol 8: 379-387. doi:10.1006/scbi.1998.0100. PubMed: 10101803.
33. Wang WJ, Kuo JC, Yao CC, Chen RH (2002) DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 159: 169-179. doi:10.1083/jcb.200204050. PubMed: 12370243.
34. Giuliano CJ, Kerley-Hamilton JS, Bee T, Freemantle SJ, Manickaratnam R et al. (2005) Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta 1731: 48-56. doi:10.1016/j.bbaexp.2005.08. 006. PubMed: 16168501.
35. Beyrouthy MJ, Garner KM, Hever MP, Freemantle SJ, Eastman A et al. (2009) High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res 69: 9360-9366. doi:10.1158/0008-5472.CAN-09-1490. PubMed: 19951990.